Imaging techniques in medications development: preclinical and clinical aspects
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Rockville, Md.
National Inst. on Drug Abuse
1994
|
| Schriftenreihe: | National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series
138 |
| Schlagworte: | |
| Beschreibung: | IV, 193 S. Ill., graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV009842289 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 941012s1994 ad|| |||| 00||| eng d | ||
| 035 | |a (OCoLC)30538881 | ||
| 035 | |a (DE-599)BVBBV009842289 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 | ||
| 050 | 0 | |a RC78.7.D53 | |
| 082 | 0 | |a 616.07/54 |2 20 | |
| 245 | 1 | 0 | |a Imaging techniques in medications development |b preclinical and clinical aspects |c ed.: Heinz Sorer ... |
| 264 | 1 | |a Rockville, Md. |b National Inst. on Drug Abuse |c 1994 | |
| 300 | |a IV, 193 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series |v 138 | |
| 650 | 4 | |a Diagnostic Imaging |x methods | |
| 650 | 4 | |a Diagnostic imaging | |
| 650 | 4 | |a Drug Design | |
| 650 | 4 | |a Drug Evaluation | |
| 650 | 0 | 7 | |a Neurotransmitter |0 (DE-588)4041905-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Halluzinogen |0 (DE-588)4134941-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Hirnfunktion |0 (DE-588)4159930-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Psychopharmakon |0 (DE-588)4047729-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Neuropharmakologie |0 (DE-588)4041896-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Bildgebendes Verfahren |0 (DE-588)4006617-4 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Hirnfunktion |0 (DE-588)4159930-5 |D s |
| 689 | 0 | 1 | |a Neurotransmitter |0 (DE-588)4041905-8 |D s |
| 689 | 0 | 2 | |a Bildgebendes Verfahren |0 (DE-588)4006617-4 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Halluzinogen |0 (DE-588)4134941-6 |D s |
| 689 | 1 | 1 | |a Neuropharmakologie |0 (DE-588)4041896-0 |D s |
| 689 | 1 | 2 | |a Bildgebendes Verfahren |0 (DE-588)4006617-4 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Psychopharmakon |0 (DE-588)4047729-0 |D s |
| 689 | 2 | 1 | |a Neuropharmakologie |0 (DE-588)4041896-0 |D s |
| 689 | 2 | 2 | |a Bildgebendes Verfahren |0 (DE-588)4006617-4 |D s |
| 689 | 2 | |5 DE-604 | |
| 700 | 1 | |a Sorer, Heinz |e Sonstige |4 oth | |
| 830 | 0 | |a National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series |v 138 |w (DE-604)BV001902214 |9 138 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-006517258 | ||
Datensatz im Suchindex
| _version_ | 1804124199403388928 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV009842289 |
| callnumber-first | R - Medicine |
| callnumber-label | RC78 |
| callnumber-raw | RC78.7.D53 |
| callnumber-search | RC78.7.D53 |
| callnumber-sort | RC 278.7 D53 |
| callnumber-subject | RC - Internal Medicine |
| ctrlnum | (OCoLC)30538881 (DE-599)BVBBV009842289 |
| dewey-full | 616.07/54 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.07/54 |
| dewey-search | 616.07/54 |
| dewey-sort | 3616.07 254 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02207nam a2200565 cb4500</leader><controlfield tag="001">BV009842289</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">941012s1994 ad|| |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)30538881</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV009842289</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC78.7.D53</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.07/54</subfield><subfield code="2">20</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Imaging techniques in medications development</subfield><subfield code="b">preclinical and clinical aspects</subfield><subfield code="c">ed.: Heinz Sorer ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Rockville, Md.</subfield><subfield code="b">National Inst. on Drug Abuse</subfield><subfield code="c">1994</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">IV, 193 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series</subfield><subfield code="v">138</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Diagnostic Imaging</subfield><subfield code="x">methods</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Diagnostic imaging</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Design</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Evaluation</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Neurotransmitter</subfield><subfield code="0">(DE-588)4041905-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Halluzinogen</subfield><subfield code="0">(DE-588)4134941-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hirnfunktion</subfield><subfield code="0">(DE-588)4159930-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Psychopharmakon</subfield><subfield code="0">(DE-588)4047729-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Neuropharmakologie</subfield><subfield code="0">(DE-588)4041896-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Bildgebendes Verfahren</subfield><subfield code="0">(DE-588)4006617-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Hirnfunktion</subfield><subfield code="0">(DE-588)4159930-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Neurotransmitter</subfield><subfield code="0">(DE-588)4041905-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Bildgebendes Verfahren</subfield><subfield code="0">(DE-588)4006617-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Halluzinogen</subfield><subfield code="0">(DE-588)4134941-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Neuropharmakologie</subfield><subfield code="0">(DE-588)4041896-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Bildgebendes Verfahren</subfield><subfield code="0">(DE-588)4006617-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Psychopharmakon</subfield><subfield code="0">(DE-588)4047729-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Neuropharmakologie</subfield><subfield code="0">(DE-588)4041896-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="2"><subfield code="a">Bildgebendes Verfahren</subfield><subfield code="0">(DE-588)4006617-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sorer, Heinz</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series</subfield><subfield code="v">138</subfield><subfield code="w">(DE-604)BV001902214</subfield><subfield code="9">138</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-006517258</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| id | DE-604.BV009842289 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T17:41:52Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-006517258 |
| oclc_num | 30538881 |
| open_access_boolean | |
| owner | DE-12 |
| owner_facet | DE-12 |
| physical | IV, 193 S. Ill., graph. Darst. |
| publishDate | 1994 |
| publishDateSearch | 1994 |
| publishDateSort | 1994 |
| publisher | National Inst. on Drug Abuse |
| record_format | marc |
| series | National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series |
| series2 | National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series |
| spelling | Imaging techniques in medications development preclinical and clinical aspects ed.: Heinz Sorer ... Rockville, Md. National Inst. on Drug Abuse 1994 IV, 193 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series 138 Diagnostic Imaging methods Diagnostic imaging Drug Design Drug Evaluation Neurotransmitter (DE-588)4041905-8 gnd rswk-swf Halluzinogen (DE-588)4134941-6 gnd rswk-swf Hirnfunktion (DE-588)4159930-5 gnd rswk-swf Psychopharmakon (DE-588)4047729-0 gnd rswk-swf Neuropharmakologie (DE-588)4041896-0 gnd rswk-swf Bildgebendes Verfahren (DE-588)4006617-4 gnd rswk-swf (DE-588)1071861417 Konferenzschrift gnd-content Hirnfunktion (DE-588)4159930-5 s Neurotransmitter (DE-588)4041905-8 s Bildgebendes Verfahren (DE-588)4006617-4 s DE-604 Halluzinogen (DE-588)4134941-6 s Neuropharmakologie (DE-588)4041896-0 s Psychopharmakon (DE-588)4047729-0 s Sorer, Heinz Sonstige oth National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series 138 (DE-604)BV001902214 138 |
| spellingShingle | Imaging techniques in medications development preclinical and clinical aspects National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series Diagnostic Imaging methods Diagnostic imaging Drug Design Drug Evaluation Neurotransmitter (DE-588)4041905-8 gnd Halluzinogen (DE-588)4134941-6 gnd Hirnfunktion (DE-588)4159930-5 gnd Psychopharmakon (DE-588)4047729-0 gnd Neuropharmakologie (DE-588)4041896-0 gnd Bildgebendes Verfahren (DE-588)4006617-4 gnd |
| subject_GND | (DE-588)4041905-8 (DE-588)4134941-6 (DE-588)4159930-5 (DE-588)4047729-0 (DE-588)4041896-0 (DE-588)4006617-4 (DE-588)1071861417 |
| title | Imaging techniques in medications development preclinical and clinical aspects |
| title_auth | Imaging techniques in medications development preclinical and clinical aspects |
| title_exact_search | Imaging techniques in medications development preclinical and clinical aspects |
| title_full | Imaging techniques in medications development preclinical and clinical aspects ed.: Heinz Sorer ... |
| title_fullStr | Imaging techniques in medications development preclinical and clinical aspects ed.: Heinz Sorer ... |
| title_full_unstemmed | Imaging techniques in medications development preclinical and clinical aspects ed.: Heinz Sorer ... |
| title_short | Imaging techniques in medications development |
| title_sort | imaging techniques in medications development preclinical and clinical aspects |
| title_sub | preclinical and clinical aspects |
| topic | Diagnostic Imaging methods Diagnostic imaging Drug Design Drug Evaluation Neurotransmitter (DE-588)4041905-8 gnd Halluzinogen (DE-588)4134941-6 gnd Hirnfunktion (DE-588)4159930-5 gnd Psychopharmakon (DE-588)4047729-0 gnd Neuropharmakologie (DE-588)4041896-0 gnd Bildgebendes Verfahren (DE-588)4006617-4 gnd |
| topic_facet | Diagnostic Imaging methods Diagnostic imaging Drug Design Drug Evaluation Neurotransmitter Halluzinogen Hirnfunktion Psychopharmakon Neuropharmakologie Bildgebendes Verfahren Konferenzschrift |
| volume_link | (DE-604)BV001902214 |
| work_keys_str_mv | AT sorerheinz imagingtechniquesinmedicationsdevelopmentpreclinicalandclinicalaspects |